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EMERGENCY PROCEDURES
Police/Fire/Ambulance and Chemical or Biological Spill Response




Dial 9-1-1 from any campus phone.
Dial 908-737-4800 from a cell phone.
Hit the red button on any outdoor Blue Light Telephone.

Treatment for Minor Injuries and Illness
To obtain treatment for a non-life threatening workplace exposure, injury, or illness, contact
Human Resources at 908-737-3300. If the incident occurs during non-business hours, go to
the nearest hospital emergency room, and report the incident to Human Resources on the next
business day.
Building-Related Emergencies
Facilities and Campus Planning should be contacted for any building-related emergency at
908-737-5000.
Work requests can be placed online for routine maintenance or housekeeping tasks at
http://www.kean.edu/KU/Facilities-and-Campus-Planning.

INTRODUCTION
Kean University is committed to provide a safe and healthful work environment for our entire
staff. In pursuit of this endeavor, the following Exposure Control Plan (ECP) is provided to
eliminate or minimize occupational exposure to bloodborne pathogens in accordance with the
PEOSH Bloodborne Pathogens Standard, Title 29 Code of Federal Regulations 1910.1030.
The ECP is a key document to assist Kean University in implementing and ensuring
compliance with the standard, thereby protecting our employees. This ECP includes:




Employee exposure determination.
The procedures for evaluating the circumstances surrounding an exposure incident, and
The schedule and method for implementing the specific sections of the standard,
including:
o
o
o
o




Methods of compliance
Hepatitis B vaccination and post-exposure follow-up
Training and communication of hazards to employees
Recordkeeping

Biological Safety Practices for Laboratories
Sharps evaluation and injury log
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PROGRAM ADMINISTRATION
The success of the program relies on both management and employees. The following are
roles and responsibilities for each.
Management Responsibilities








Human Resources and the Office of Environmental Health and Safety (EHS) are
responsible for the implementation of the ECP. EHS will maintain and update the
written ECP at least annually and whenever necessary to include new or
modified tasks and procedures.
Facilities and Campus Planning is responsible for written housekeeping protocols
and will ensure that effective disinfectants are purchased for the campus. Health
Services, Athletic Training, and Biological Sciences will maintain departmentspecific protocols and disinfectants.
Human Resources shall be responsible for ensuring that all medical actions
required are performed and that appropriate medical records are maintained.
EHS shall ensure that training, documentation of training, and making the written
ECP available to employees, PEOSH and NIOSH representatives.
Each affected department, in consultation with EHS, shall maintain and provide
all necessary personal protective equipment (PPE), engineering controls (i.e.,
sharp containers, self-sheathing needles, etc.), labels and red bags as required
by the standard and will ensure that adequate supplies of the aforementioned
equipment are available.

Employee Responsibilities
Those employees who are reasonably anticipated to have contact with or exposure to blood or
other potentially infectious materials are required to comply with the procedures and work
practices outlined in this ECP.
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EMPLOYEE EXPOSURE DETERMINATION
All exposure determinations were made without regard to the use of Personal Protective
Equipment (PPE).
Table 1 – Job Titles and Tasks with Occupational Exposure
Department or Area

Job Titles in which
ALL employees have
occupational
exposure

Academic Affairs

Athletics Department

Physicians,
Athletic trainers,
Lifeguards

Childcare Center

Job Titles in which
SOME employees
have occupational
exposure…

….and the tasks and
procedures where the
occupational
exposure can occur.

Faculty and Staff in
Biology, Medical
Technology, and all
Sciences

Working with human blood
or human-derived
materials, including human
cell lines and unfixed
human specimens in the
classroom or in research.

Clinical Faculty and Staff in
Nursing, Occupational
Therapy, Physical Therapy,
The Physician’s Assistant
program, and the
School of Communication
Disorders and Deafness

Working in a clinical area
and providing direct patient
care.

Coaches,
Equipment Manager

First Aid; handling
contaminated equipment or
uniforms; cleaning up
blood or other body fluids
First Aid; Diapering and
Toileting; cleaning up blood
or other body fluids

Faculty and staff who
provide direct care to
children.

Department of Public
Safety and Police

Director,
Sworn officers,
Security officers

Liberty Hall Museum

Plumbers,
Senior Building
Maintenance Workers

Office of Environmental
Health and Safety

All Staff

Office of Residence Life

Plumbers,
Senior Building
Maintenance Workers

Student Health Services

Physicians,
Nurses

Residence Hall Directors,
Resident Advisors

First Aid

Good Samaritan Acts
“Good Samaritan” acts which result in exposure to blood or other potentially infectious materials from
assisting a fellow employee, student, or visitor (i.e., assisting a coworker with nosebleed, giving CPR
or first aid) are not included in the Bloodborne Pathogens Standard. However, Kean University will
offer post-exposure evaluation and follow-up in such cases.
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METHODS OF IMPLEMENTATION AND CONTROL
Exposure Control Plan (ECP)
Employees covered by the Bloodborne Pathogens Standard will receive an explanation of this
ECP during their initial training session. It will also be reviewed in their annual refresher
training. All employees will have an opportunity to review this Plan at any time during their
work shifts and/or request a copy by contacting EHS. A copy of the Plan will be made
available free of charge and within 15 days of the request.
EHS will be responsible for reviewing and updating the ECP annually or sooner if necessary to
reflect any new or modified tasks and procedures which affect occupational exposure and to
reflect new or revised employee positions with occupational exposure.
Universal Precautions/Standard Precautions
Universal Precautions is an infection control method which requires employees to assume that
all human blood and specified human body fluids are infectious for HIV, HBV, HCV, and other
bloodborne pathogens and must be treated accordingly.
Standard Precautions extend Universal Precautions, and are the minimum infection prevention
practices that apply to all patient care, regardless of suspected or confirmed infection status of
the patient, in any setting where healthcare is delivered. These practices are designed to both
protect staff and prevent the spread of infections among patients.
Standard Precautions include: 1) hand hygiene, 2) use of personal protective equipment (e.g.,
gloves, gowns, masks), 3) safe injection practices, 4) safe handling of potentially contaminated
equipment or surfaces in the patient environment, and 5) respiratory hygiene/cough etiquette.
Employees are required to utilize Standard Precautions.
Engineering Controls
Engineering controls and work practice controls will be used to prevent or minimize exposure
to bloodborne pathogens. The following engineering controls are used, as needed, throughout
the facility.
 Sharps Containers
 Red bags and Medical Waste Containers
 Elimination of needle-bearing devices, and when the elimination of needle-bearing
devices is not possible, needle devices with safety features
 Hand Washing Facilities
 Biological Safety Cabinets
 Mechanical pipetting devices
 Autoclaves
 Work carried out on spill trays or pans, or using bench paper
 Centrifuge safety devices (safety cups, sealed rotors)
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 Vacuum line filter systems/chemical disinfection traps
 Specimen transport containers

Minimum Work Practices to be Observed
The following work practices, as a minimum, shall be observed in areas where blood or other
potentially infectious materials are present:















Eating, drinking, smoking, applying cosmetics or lip balm and handling contact lenses in
work area where there is a likelihood of occupational exposure is prohibited.
Food and drink shall not be stored in refrigerators, freezers, shelves, cabinets or on
counter tops or bench tops where blood or other potentially infectious materials are or
were present.
All employees must wash their hands immediately, or as soon as feasible, after removal
of gloves or other personal protective equipment.
Handwashing is also required: before touching a patient, even if gloves will be worn;
before exiting the patient’s care area after touching the patient or the patient’s
immediate environment; after contact with blood, body fluids or excretions, or wound
dressings; prior to performing an aseptic task (e.g., placing an IV, preparing an
injection); If hands will be moving from a contaminated-body site to a clean-body site
during patient care.
Procedures involving blood or other potentially infectious materials shall be performed in
such a manner as to minimize splashing, splattering, and generation of droplets of these
substances.
Mouth pipetting is prohibited.
Specimens of blood or other potentially infectious materials shall be transported in a
container which prevents leakage during collection, handling, processing, storage,
transport or shipping.
Equipment which may become contaminated with blood or other potentially infectious
materials shall be examined prior to servicing or shipping and shall be decontaminated
such equipment as necessary. Items will be labeled per the standard if not completely
decontaminated.
Contaminated surfaces shall be clean immediately or as soon as feasibly possible.
Contaminated needles and other contaminated sharps are not bent, recapped or
removed unless: (1) It can be demonstrated that there is no feasible alternative, or (2)
The action is required by a specific medical or research procedure. In the two situations
above, the recapping or needle removal is accomplished through the use of
a mechanical device or a one-handed scoop technique.
Contaminated sharps are placed in appropriate containers immediately, or as soon as
possible after use. Containers should be disposed of when approximately 2/3 full.
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PERSONAL PROTECTIVE EQUIPMENT (PPE)
Personal protective equipment must be used if occupational exposure remains after instituting
engineering and work practice controls, or if the controls are not feasible. Training will be
provided by EHS or designee and the employee’s supervisor in the use of the appropriate
personal protective equipment for employees' specific job classifications and tasks/procedures
they will perform.
Additional training will be provided, whenever necessary, such as if an employee takes a new
position or if new duties are added to their current position.
Appropriate personal protective equipment is required for the tasks listed below in Table 2.
The specific equipment to be used is listed after the task.
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Table 2 – Personal Protective Equipment by Task
Task

Gloves

Eye
Protection

Gown
or
Apron

SurgicalType Mask

Lab
Coat

CPR
Mask

Foot
Covering

Administering First Aid.

Yes

As
needed

As
needed

As
needed

No

As
needed

As
needed

Cleaning up a spill of blood or other body
fluids.

Yes

As
needed

As
needed

As
needed

No

No

As
needed

Picking up the trash in a ladies’
restroom.

Yes

No

No

No

No

No

No

Repairs to toilets and when working
pipes carrying raw sewerage.

Yes

Yes

No

No

No

No

As
needed

Medical procedures/actions that require
contact with mucous membranes or
open wounds.

Yes

As
needed

As
needed

As
needed

As
needed

No

As
needed

Phlebotomy

Yes

No

As
needed

No

As
needed

No

No

Handling human blood or other humanderived materials, including human cell
lines in a classroom or laboratory setting.

Yes

Yes

As
needed

As
needed

Yes

No

No

Handling or laundering uniforms, towels,
or other items potentially contaminated
with blood or body fluids.

Yes

No

As
needed

No

No

No

No

Changing diapers and assisting with
toileting.

Yes

No

No

No

No

No

No

When touching a person with visible PIM
or OPIM on his/her person or clothing.
(“red, wet, or dirty”)

Yes

No

No

No

No

No

No

When in the vicinity of a person/arrestee
known to spit or to throw bodily fluids.

Yes

Yes

Yes

As
needed

No

No

No

Face
shield
preferred
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Available Types of Personal Protective Equipment
The following is a list of readily available PPE found within each department. Other equipment
will be purchased if needed for a task.
Police/Public Safety
Gloves, disposable: (nitrile or vinyl)
CPR Mask and/or Breathing Barriers; Resuscitation Bags and masks, for trained personnel
Eye Protection: face shield or goggles
Eye/Face Protection: Surgical masks with face shields

Health Services
Gloves, disposable: nitrile or vinyl
Face shields and goggles
Laboratory Coats
CPR Mask and/or Breathing Barriers; Resuscitation Bags and masks, for trained personnel

Lifeguard/Pool Area
Gloves
CPR Mask
Gown
Eye/Face Protection: Surgical masks with face shields

Facilities
Gloves, disposable: nitrile or vinyl
Gloves, re-useable, cleaned after each use
Eye Protection: goggles and face shields

Environmental Health and Safety
Gloves, disposable: nitrile or vinyl
Gloves, re-useable: cleaned after use
Laboratory Coats, disposable
Eye Protection: goggles and face shields

Athletics
Gloves, disposable: nitrile or vinyl
Eye Protection: goggles and face shields
CPR Mask
Gown
Eye/Face Protection: Surgical masks with face shields

Daycare
Gloves, disposable: nitrile or vinyl
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Required Work Practices when wearing PPE














Wash hands immediately or as soon as feasible using clean running water and soap after
removal of gloves or other personal protective equipment. Hand sanitizer may be used in
situations where soap and water are not readily available and the hands are not visibly
soiled.
Remove protective equipment before leaving the work area and after a garment becomes
contaminated.
Place used protective equipment in appropriately designated areas or containers being
stored, washed, decontaminated, or discarded.
Wear appropriate gloves when it can be reasonably anticipated that you may have contact
with blood or other potentially infectious materials and when handling or touching
contaminated items or surfaces. Replace gloves if torn, punctured, contaminated, or if their
ability to function as a barrier is compromised.
Following any contact of body areas with blood or any other infectious materials, you must
wash your hands and any other exposed skin with soap and water as soon as possible.
Employees must also flush exposed mucous membranes (eyes, mouth, etc) with water.
Discard utility gloves when they show signs of cracking, peeling, tearing, puncturing, or
deterioration.
Never wash or decontaminate disposable gloves for reuse or before disposal.
Wear appropriate face and eye protection such as a mask with glasses with solid side
shields or a chin-length face shield when splashes, sprays, splatters, or droplets of blood or
other potentially infectious materials pose a hazard to the eye, nose, or mouth.
If a garment is penetrated by blood and other potentially infectious materials, the
garment(s) must be removed immediately or as soon as feasible. If a pullover scrub (as
opposed to scrubs with snap closures) becomes minimally contaminated, employees
should be trained to remove the pullover scrub in such a way as to avoid contact with the
outer surface; e.g., rolling up the garment as it is pulled toward the head for removal.
However, if the amount of blood exposure is such that the blood penetrates the scrub and
contaminates the inner surface, not only is it impossible to remove the scrub without
exposure to blood, but the penetration itself would constitute exposure. It may be prudent
to train employees to cut such a contaminated scrub to aid removal and prevent exposure
to the face.
Repair and/or replacement of PPE will be at no cost to employees.
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TRAINING
Each employee who has or is reasonably anticipated to have occupational exposure to
bloodborne pathogens will receive training conducted by EHS or a qualified individual
designated by his/her department.
The training program will cover, at a minimum, the following elements:














Access to a copy of the standard and explanation of its contents
Epidemiology and symptoms of bloodborne pathogens
Modes of transmission
Details of the facility’s Exposure Control Plan and how to obtain a copy
Methods to recognize exposure tasks and other activities that may involve exposure to
blood
Use and limitations of Engineering Controls, Work Practices, and PPE
PPE - types, use, location, removal, handling, decontamination, and disposal
PPE - the basis for selection
Information on the Hepatitis B vaccine program. Training will be given prior to
vaccination on its safety, effectiveness, benefits, and method of administration
Emergency procedures for occupational incidents involving exposures to blood and
other potentially infectious materials
Post-exposure evaluation and follow-up information and procedures
Signs and labels used in this facility
Questions and answer session

An Employee Education and Training Record will be completed for each employee upon
completion of training. This document will be kept at the EHS office.
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LABELING
Kean University will affix warning labels to:







containers of regulated waste;
containers of contaminated reusable sharps;
refrigerators and freezers containing blood or OPIM;
other containers used to store, transport, or ship blood or OPIM;
equipment that is being shipped or serviced, if it cannot be completely decontaminated
prior to shipment or servicing; and
bags or containers of contaminated laundry, unless red bags are used.

Labeling requirements:






Labels will have both the biohazard symbol and the word “BIOHAZARD” as illustrated in
Figure 1.
Be fluorescent orange or orange-red or predominantly so, with lettering and symbols in
a contrasting color;
Affixed as close as feasible to the container by string, wire, adhesive, or other method
that prevents their loss or unintentional removal.
Red bags or red containers may be substituted for labels.
Labels required for contaminated equipment shall be in accordance with this paragraph
and shall also state which portions of the equipment remain contaminated.

Figure 1 – Example of an Acceptable Label
(Please note: If this document has been reproduced in black and white,
the label above has black text on a bright orange background.)
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HEPATITIS B VACCINATIONS
The training program will provide information on hepatitis B vaccinations addressing its safety,
benefits, efficacy, methods of administration and availability. The hepatitis B vaccination
series will be made available at no cost within 10 days of initial assignment of employees who
have occupational exposure to blood or other potentially infectious materials unless:





the employee has previously received the series,
antibody testing reveals that the employee is immune,
medical reasons prevent taking the vaccination, or
the employee chooses not to participate.

Hepatitis B vaccination will be provided by the University’s designated occupational health clinic, with
the appointment scheduled by Human Resources.
Declining the Vaccination
All employees are strongly encouraged to receive the hepatitis B vaccination series. However,
if an employee chooses to decline the vaccination, then the employee must sign a form stating
the following statement (from 29 CFR 1910.1030 App A):
Declination Statement
I understand that due to my occupational exposure to blood or other potentially infectious materials I may
be at risk of acquiring Hepatitis B virus (HBV) infection. I have been given the opportunity to be
vaccinated with hepatitis B vaccine, at no charge to me; however, I decline hepatitis B vaccination at this
time. I understand that by declining this vaccine I continue to be at risk of acquiring hepatitis B, a serious
disease. If, in the future I continue to have occupational exposure to blood or other potentially infectious
materials and I want to be vaccinated with hepatitis B vaccine, I can receive the vaccination series at no
charge to me.

Employees who decline may request and obtain the vaccination at a later date at no cost. The
documentation of refusal of the hepatitis B vaccination will be kept on file by EHS.
Post-Vaccination Titer Testing
The PEOSH Bloodborne Pathogens Standard requires that the most recent CDC guidelines be
followed regarding the hepatitis B vaccine and post-exposure follow-up. Therefore, employers of
New Jersey public safety workers (e.g., EMT’s, police, firefighters, corrections officers) and other
public employees (physicians, nurses) covered under the PEOSH Bloodborne Pathogens Standard
must determine if their employees are at ongoing risk for percutaneous injuries.
Kean University has identified the following job classifications as having ongoing risk for
percutaneous injuries:
o
o
o
o

Student Health Services: Physicians, Nurses
Athletics Department: Physicians
Department of Public Safety and Police: Director, Sworn officers, Security officers
Office of Environmental Health and Safety: All Staff
13

o Academic Affairs: Faculty and staff in the Sciences (e.g., Biology, Medical Technology,
and Researchers) who use sharps while working with human blood or human-derived
materials, including human cell lines and unfixed human specimens.
As a result, Kean University is required to offer blood testing to those employees 1-2 months after
completion of the 3-dose vaccination series for antibodies for hepatitis B surface antigen (antiHBs).
If the employee does not respond to the primary vaccine, Kean will consult the Center for Disease
Control for current recommendations.
The employer does not have to offer antibody testing to those employees who have been
previously vaccinated.
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POST-EXPOSURE PROCEDURES
Emergency Procedures for Exposures or Needlesticks
If you experienced a needlestick or other sharps injury, or were exposed to the blood or other
body fluid during the course of your work, follow these steps:










Remove contaminated clothing.
IMMEDIATELY irrigate eyes with clean water, saline, or sterile irrigants for 15 minutes.
IMMEDIATELY flush splashes to the nose, mouth, or skin with running water.
VIGOROUSLY wash needlesticks and cuts with soap and water for one minute with
antibacterial soap, if available.
Notify your supervisor.
o In clinical areas: EHS, the employee, a supervisor, and/or Human Resources will
identify and document the identity of the source individual, unless it can
established that identification is infeasible or prohibited by State or local law.
o If an instrument or device was involved in the incident, do NOT discard it. It may
be used for testing.
o In other areas: Kean University will attempt to identify the source person, and
obtain consent to test his/her blood. If applicable, set aside the sharp item (e.g.
tool, medical device, or weapon) involved in the incident for testing.
Report the incident to Human Resources at 908-737-3300. They will assist you in
obtaining IMMEDIATE medical treatment. During non-business hours, call Public
Safety Dispatch at 908-737-4800. Public Safety will assist you in transport (if needed)
to the emergency department of the nearest hospital. Notify Human Resources of the
incident on the next business day.
Document the injury or exposure using forms available from Human Resources. All
needlesticks, sharps injuries, and blood or other body fluid exposure will be investigated
by EHS.

Post-Exposure Evaluation by Healthcare Professional
An immediately available confidential medical evaluation and follow-up will be provided by the
University’s designated occupational health clinic or a hospital emergency room. If the
clinician has a question about the appropriate medical treatment for occupational exposures,
24-hour assistance is available from the Clinicians' Post Exposure Prophylaxis Hotline
(PEPline) at 1-888-448-4911.
The following actions will be performed:



The employee and/or EHS will document the routes of exposure and how exposure
occurred. 
EHS, the employee, supervisor, and/or Human Resources will attempt to obtain
consent from the source individual to test his/her blood to determine HBV, HCV, and
HIV infectivity.
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If the source individual consents to testing, the exposed employee will be provided with
the source individual’s test results and information about any applicable laws or
regulations concerning the disclosure of the source individual's identity and infection
status.
If the employee consents to blood testing or to baseline blood sampling, Human
Resources will arrange for the collection or exposed employee’s blood as soon as
feasible after the exposure incident and test blood for HBV and HIV serological status.
If the employee does not give consent for HIV serological testing during the collection of
blood for baseline testing, Kean University will arrange for the baseline blood sample to
be preserved for at least 90 days.
EHS will review the circumstances of the exposure incident to determine if procedures,
protocols and/or training need to be revised.

Information Provided to Healthcare Professional
EHS and/or Human Resources will ensure that health care professionals responsible for
employee’s HB vaccination and post-exposure evaluation and follow-up be given a copy of the
PEOSH Bloodborne Pathogens Standard. EHS will also ensure that the health care
professional evaluating an employee after an exposure incident receives the following:






a description of the employee's job duties relevant to the exposure incident
route(s) of exposure
circumstances of exposure
if possible, results of the source individual’s blood test; and
relevant employee medical records, including vaccination status

Healthcare Professional’s Written Opinion
The clinician will provide the employee with a copy of the evaluating healthcare professional’s
written opinion within 15 days after completion of the evaluation.
For HB vaccinations, the healthcare professional’s written opinion will be limited to whether the
employee requires or has received the HB vaccination.
The written opinion for post-exposure evaluation and follow-up will be limited to whether or not
the employee has been informed of the results of the medical evaluation and any medical
conditions which may require further evaluation and treatment.
All other diagnoses must remain confidential and not be included in the written report to our
facility.
Procedures for Evaluating an Exposure Incident
EHS will review the circumstances of all exposure incidents to determine:


engineering controls in use at the time
16










work practices followed
a description of the device being used (including type and brand)
protective equipment or clothing that was used at the time of the exposure incident (gloves,
eye shields, etc.)
location of the incident
procedure being performed when the incident occurred
employee’s training
Human Resources will record all percutaneous injuries from contaminated sharps in the
Sharps Injury Log.
If it is determined that revisions need to be made, EHS will ensure that appropriate
changes are made to this ECP. (Changes may include evaluation other, similar devices
with different safety features, adding employees to the exposure determination list, etc.)
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HOUSEKEEPING
Kean has developed and implemented a written schedule for cleaning and decontaminating
work surfaces as indicated by the standard. Any surface that is visibly contaminated will be
cleaned immediately or as soon as feasible.


Facilities and Campus Planning maintains a written schedule for routine cleaning and
disinfection of all surfaces throughout the University.



In patient care areas and in research laboratories, work surfaces will be decontaminated
with an appropriate disinfectant after completion of procedures, immediately when
overtly contaminated, after any spill of blood or other potentially infectious materials,
and at the end of the work shift when surfaces have become contaminated since the
last cleaning.



All areas will remove and replace protective coverings such as plastic wrap, aluminum
foil, bench paper, and the like, when contaminated.



Staff shall inspect and decontaminate, on a regular basis, reusable receptacles such as
bins, pails, and cans that are like to become contaminated. If contamination is visible,
clean and decontaminates receptacles immediately, or as soon as feasible.



Always use mechanical means such as tongs, forceps, or a brush and a dust pan to
pick up contaminated broken glassware; never pick up with hands even if gloves are
worn.



Store or process reusable sharps in a way that ensures safe handling.



Place regulated waste in closable and labeled or color-coded containers. When storing,
handling, transporting or shipping, place other regulated waste in containers that are
constructed to prevent leakage.



When discarding contaminated sharps (including safer medical devices), place them in
containers that are closable, puncture-resistant, appropriately labeled or color-coded,
and leak-proof on the sides and bottom.



Ensure that the sharps containers are easily accessible to personnel and located as
close as feasible to the immediate area where sharps are used or can be reasonably
anticipated to be found. Sharps containers also must be kept upright throughout use,
replaced routinely, closed when moved, and not allowed to overfill.



Never manually open, empty, or clean reusable contaminated sharps disposal
containers.



Discard all regulated waste according to federal, state, and local regulations, i.e., liquid
or semi-liquid blood or other potentially infectious material; items contaminated with
blood or other potentially infectious materials that would release these substances in a
18

liquid or semi-liquid state if compressed; items caked with dried blood or other
potentially infectious materials and capable of releasing these materials during handling;
contaminated sharps; and pathological and microbiological wastes containing blood or
other potentially infectious materials.
Spill Clean-up Procedure
NOTES:
1. Bleach solutions should not be used on fabric, carpeting, or bare metal surfaces.
2. Other EPA-registered antimicrobial products such as tuberculocides (EPA List B), sterilants (EPA List
A), and products registered against HIV/HBV (EPA List E) may be substituted for the bleach solution.
Consult the manufacture’s instructions for use.
3. For small spills, disposal germicidal wipes can be used. Consult the manufacture’s instructions for
use.



Block off the area of the spill until clean-up and disinfection is complete.



Put on eye protection and disposable gloves. Wear shoe covers or water-resistant
boots over your shoes if you may step in the spill while cleaning it up.



Prepare a 10% bleach solution – Add one part household bleach to nine parts cool
water (1 ½ cups of bleach per gallon of water, or 3 ounces (90 ml) of bleach per 32
ounces of water) and gently mix the solution.



Place paper towels over the spill.



Gently pour bleach solution onto the paper towels covering the spill.



Let the bleach solution remain on the spill for 20 minutes.



Pick up the paper towels with tongs or a broom and dustpan. Place the waste in a red
biohazard bag.



Wipe up the remaining bleach solution with paper towels, and place them in the
biohazard bag.



Wipe the area down with the bleach solution using fresh paper towels, and place the
waste in the biohazard bag.



Allow the area to air dry.



All non-disposable equipment, as tongs, mops, brushes, dust pans, or overboots should
be disinfected by soaking with the bleach solution and air dried. Wipe the mop handle
with a fresh paper towels damped with bleach solution.



When finished, remove gloves and shoe covers and place in the biohazard bag with all
soiled cleaning materials. Securely tie-up the bag.

 Thoroughly wash hands with soap and water.
 Contact EHS for disposal of the waste.
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LAUNDERING/CLEANING OF CONTAMINATED
APPAREL AND ACCESSORIES

With regard to contaminated personal protective equipment, OSHA has stated in CPL 02-02069 XIII.D.16, that “Home laundering of contaminated items is unacceptable because the
employer cannot ensure that proper handling or laundering procedures are being followed and
because contamination could migrate to the homes of employees" Employers are responsible
for cleaning, laundering and/or disposing of personal protective equipment [29 CFR
1910.1030(d)(3)(iv)].
With that in mind:







Kean University will clean or replace items, at its discretion, at no cost to the employee.
Athletics uniforms, practice apparel (t-shirts, sweatpants, shorts), and towels will be
laundered in-house at D’Angola or discarded in red bag waste when contaminated.
Uniforms for Maintenance staff will be laundered by an outside vendor under contract to
the University or discarded in red bag waste when contaminated.
Police and Security uniforms will be are laundered or dry cleaned by an outside vendor
or discarded in red bag waste when contaminated.
Soiled leather items (belts, shoes, gloves) will be scrubbed clean using a brush and hot
water or discarded in red bag waste when contaminated.
The method used to clean other fabric items will be on a case-by-case basis.

Contaminated Laundry Handling Procedures












Use appropriate personal protective equipment when handling contaminated laundry.
Place wet contaminated laundry in leak-proof, labeled or color-coded containers or bags
before transporting.
Bag contaminated laundry at its location of use. Never sort or rinse contaminated
laundry in areas of its use.
Red laundry bags or those marked with the biohazard symbol unless universal
precautions are in use at the facility and all employees recognize the bags as
contaminated and have been trained in handling the bags.
If contaminated laundry is sent off-site, Kean will determine if the receiving facility uses
universal precautions. If universal precautions are not used, then Kean will place the
contaminated laundry in red bags. Red bags are available from EHS.
When handling and/or sorting contaminated/potentially contaminated laundry, gloves
and other appropriate personal protective equipment shall be worn.
Handle contaminated laundry as little as possible and with a minimum of agitation.
Dry cleaning is an acceptable method for decontamination.
If hot water is used, linen should be washed with detergent in water at least 140F 160F for 25 minutes. If low-temperature (<140F) laundry cycles are used, chemicals
suitable for low-temperature washing at proper use concentration should be used.
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RECORDKEEPING
Medical Records
Medical records are maintained for each employee with occupational exposure in accordance
with 29 CFR 1910.1020, “Access to Employee Exposure and Medical Records.”
Human Resources is responsible for maintenance of the required medical records and they
are kept at Administration Building.
In addition to the requirements of 29 CFR 1910.1020, the medical record will include:





The name and social security number of employee;
A copy of the employee's hepatitis B vaccinations and any medical records relative to the
employee's ability to receive vaccination;
A copy of all results of examinations, medical testing, and follow-up procedures as required
by the standard;
A copy of all healthcare professional’s written opinion(s) as required by the standard.

All employee medical records will be kept confidential and will not be disclosed or reported
without the employee’s express written consent to any person within or outside the workplace
except as required by the standard or as may be required by law.
Employee medical records shall be confidential and maintained for at least the duration of
employment plus 30 years in accordance with 29 CFR 1910.1020.
Employee medical record shall be provided upon request of the employee or to anyone having
written consent of the employee within 15 working days.
Training Records
Bloodborne pathogen training records will be maintained by EHS. The training record shall
include:


the dates of the training sessions;



the contents or a summary of the training sessions;



the names and qualifications of persons conducting the training;



the names and job titles of all persons attending the training sessions.

Training records will be maintained for a minimum of three (3) years from the date on which
the training occurred. Employee training records will be provided upon request to the
employee or the employee's authorized representative within 15 working days.
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PEOSH Recordkeeping
Each exposure incident is evaluated to determine if the case meets PEOSH’s Recordkeeping
Requirements (29 CFR 1904). This determination and the recording activities are done by
EHS and Human Resources.
Sharps Injury Log Requirements
In addition to the 29 CFR 1904 Recordkeeping Requirements, all percutaneous injuries from
contaminated sharps are also recorded in the Sharps Injury Log. All incidences must include
at least:





the date of the injury
the type and brand of the device involved
the department or work area where the incident occurred
an explanation of how the incident occurred

This log is reviewed at least annually by EHS as part of the annual evaluation of the program
and is maintained for at least five years following the end of the calendar year that they cover.
If a copy is provided to an interested party, all personal identifiers must be removed from the
report.

Table 3 - Sharps Injury Log

Date

Type of Device
(e.g., syringe, suture
needle)

Brand Name
of Device

Work Area were
injury occurred

Brief description of how
the incident occurred

No reported sharps injuries for 2009
No reported sharps injuries for 2010
No reported sharps injuries for 2011
No reported sharps injuries for 2012
No reported sharps injuries for 2013
No reported sharps injuries for 2014
No reported sharps injuries for 2015
No reported sharps injuries for 2016
No reported sharps injuries for 2017
No reported sharps injuries for 2018

Transfer of Records
If Kean University ceases to do business and there is no successive employer to receive and
retain the records for the prescribed period, the employer shall notify the Director of the
National Institute for Occupational Safety and Health (NIOSH) at least three (3) months prior to
scheduled record disposal and prepare to transmit them to the Director.
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SHARPS EVALUATION PROGRAM
Clinical use of sharps is limited to Student Health Services. As such, the sharps evaluation
program will be limited to the staff of Student Health Services. All staff who use sharps will be
asked to participate in the evaluation of the sharps in use, utilizing the form below.
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Figure 2 - Safety Feature Evaluation Form for Safety Syringes
Product: ____________________________________

Date: _________

Please circle or mark the check box of the most appropriate answer for each question. Not applicable (N/A) may
be used if the question does not apply to this particular product.

1.

The safety feature can be activated using a one-handed technique ....................................... Agree Disagree

N/A

2.

The safety feature does not obstruct vision of the tip of the sharp ......................................... Agree Disagree

N/A

3.

Use of this product requires you to use the safety feature ...................................................... Agree Disagree

N/A

4.

This product does not require more time to use than a non-safety device .............................. Agree Disagree

N/A

5.

The device is easy to handle while wearing gloves ................................................................. Agree Disagree

N/A

6.

The device is easy to handle while wet ................................................................................... Agree Disagree
This device offers a good view of the dosage/aspirated fluid .................................................. Agree Disagree

N/A
N/A

7.

This device will work with all required syringe and needle sizes ............................................. Agree Disagree

N/A

8.

The device is equally satisfactory for different patient
populations (older, younger, heavy, thin, etc.) ....................................................................... Agree Disagree

N/A

The device can be used without causes more patient discomfort
than other devices ................................................................................................................... Agree Disagree

N/A

10. The device does not increase the number of sticks to the patient........................................... Agree Disagree

N/A

11. There is a clear and unmistakable change (audible or visible) that occurs
when the safety feature is activated ........................................................................................ Agree Disagree

N/A

12. The safety feature operates reliably ........................................................................................ Agree Disagree

N/A

13. The exposed sharp is permanently blunted or covered after use and prior to disposal .......... Agree Disagree

N/A

14. This device is no more difficult to dispose of after use than non-safety devices ..................... Agree Disagree

N/A

15. The user does not need extensive training for correct operation ............................................ Agree Disagree

N/A

16. The design of the device suggests proper use........................................................................ Agree Disagree

N/A

17. It is not easy to skip a crucial step in proper use of the device ............................................... Agree Disagree

N/A

9.

18. How long have you been using this device?
 It is new to me.  Less than a month  >1 month but < 3 months  >3 months
19. About how many times did you use this syringe before you were comfortable using it?
 1 time  5 times  10 times  15 times  20 times  I never felt comfortable
20. Do you consider yourself?:  Right-handed
21. What size glove do you wear?

 Left-handed

 Extra small  Small  Medium  Large  Extra Large

22. Of the above questions, which three are the most important to you when considering your safety when using this
product?

23. Are there other questions which you feel should be asked regarding the safety/utility of this product?
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BIOSAFETY IN RESEARCH, CLINICAL, AND
STUDENT TEACHING LABORATORIES
Introduction
Good laboratory practice dictates that laboratories working with biological agents and materials
adopt standard work practices and procedures that are capable of protecting staff, students,
and the surrounding community, and that meet the requirements of federal and state
regulations. The information below is distilled from the Center for Disease Control, National
Institutes of Health Publication, “Biosafety in Microbiological and Biomedical Laboratories”
(BMBL) 5th Edition.

Biosafety Level 1 (BSL1)
Biosafety Level 1 practices, safety equipment, and facility design and construction are
appropriate for undergraduate and secondary educational training and teaching laboratories,
and for other laboratories in which work is done with defined and characterized strains of
viable microorganisms not known to consistently cause disease in healthy adult humans.
Bacillus subtilis, Nigeria gruberi, infectious canine hepatitis virus, and exempt organisms under
the NIH Guidelines are representative of microorganisms meeting these criteria.
Many agents not ordinarily associated with disease processes in humans are, however,
opportunistic pathogens and may cause infection in the young, the aged, and immunodeficient
or immunosuppressed individuals. Vaccine strains that have undergone multiple in vivo
passages should not be considered avirulent simply because they are vaccine strains. BSL-1
represents a basic level of containment that relies on standard microbiological practices with
no special primary or secondary barriers recommended, other than a sink for hand washing.
Biosafety Level 2 (BSL2)
Biosafety Level 2 practices, equipment, and facility design and construction are applicable to
clinical, diagnostic, teaching, and other laboratories in which work is done with the broad
spectrum of indigenous moderate-risk agents that are present in the community and
associated with human disease of varying severity.
With good microbiological techniques, these agents can be used safely in activities conducted
on the open bench, provided the potential for producing splashes or aerosols is low. Hepatitis
B virus, HIV, the Salmonella, and Toxoplasma are representative of microorganisms assigned
to this containment level. BSL-2 is appropriate when work is done with any human-derived
blood, body fluids, tissues, or primary human cell lines where the presence of an infectious
agent may be unknown.
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Working with Human, Non-Human Primate and Other Mammalian Cells and Tissues
Although risk of laboratory infection from working with cell cultures in general is low, risk
increases when working with human and other primate cells, and primary cells from other
mammalian species. There are reports of infection of laboratory workers handling primary
rhesus monkey kidney cells, and the bloodborne pathogen risks from working with primary
human cells, tissues and body fluids are widely recognized.
Potential Laboratory Hazards
1. Potential laboratory hazards associated with human cells and tissues include the
bloodborne pathogens HBV, HIV, HCV, HTLV, EBV, HPV and CMV as well as agents
such as Mycobacterium tuberculosis that may be present in human lung tissue.
2. Other primate cells and tissues also present risks to laboratory workers.
3. Cells immortalized with viral agents such as SV-40, EBV adenovirus or HPV, as well as
cells carrying viral genomic material also present potential hazards to laboratory
workers.
4. Tumorigenic human cells also are potential hazards as a result of self-inoculation.
There has been one reported case of development of a tumor from an accidental
needle-stick.
5. Laboratory workers should never handle autologous cells or tissues.
6. NHP cells, blood, lymphoid and neural tissues should always be considered potentially
hazardous.

Standard Microbiological Practices
1. The laboratory supervisor must enforce the institutional policies that control access to
the laboratory.
2. All persons entering the laboratory must be advised of the potential hazards and meet
specific entry/exit requirements.
a. Personal health status may impact an individual’s susceptibility to infection,
ability to receive immunizations or prophylactic interventions. Therefore, all
laboratory personnel and particularly women of childbearing age should be
provided with information regarding immune competence and conditions that
may predispose them to infection. Individuals having these conditions should be
encouraged to self-identify to the institution’s healthcare provider for appropriate
counseling and guidance.
3. The laboratory supervisor must ensure that laboratory personnel receive appropriate
training regarding their duties, the necessary precautions to prevent exposures, and
exposure evaluation procedures. Personnel must receive annual updates or additional
training when procedural or policy changes occur.
4. The laboratory supervisor must ensure that laboratory personnel demonstrate
proficiency in standard and special microbiological practices before working with BSL-2
agents.
5. Laboratory personnel must be provided medical surveillance, as appropriate, and
offered available immunizations for agents handled or potentially present in the
laboratory.
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6. Kean will evaluate the need for collection and storage of serum samples from at-risk
personnel on a case-by-case basis.
7. Persons must wash their hands after working with potentially hazardous materials and
before leaving the laboratory.
8. Eating, drinking, smoking, handling contact lenses, applying cosmetics, and storing food
for human consumption must not be permitted in laboratory areas. Food must be stored
outside the laboratory area in cabinets or refrigerators designated and used for this
purpose.
9. Mouth pipetting is prohibited; mechanical pipetting devices must be used.
10. Policies for the safe handling of sharps, such as needles, scalpels, pipettes, and broken
glassware must be implemented. Whenever practical, laboratory supervisors should
adopt improved engineering and work practice controls that reduce risk of sharps
injuries. Precautions, including those listed below, must always be taken with sharp
items. These include:
a. Careful management of needles and other sharps are of primary importance.
Needles must not be bent, sheared, broken, recapped, removed from disposable
syringes, or otherwise manipulated by hand before disposal.
b. Used disposable needles and syringes must be carefully placed in conveniently
located puncture-resistant containers used for sharps disposal.
c. Non-disposable sharps must be placed in a hard walled container for transport to
a processing area for decontamination, preferably by autoclaving.
d. Broken glassware must not be handled directly. Instead, it must be removed
using a brush and dustpan, tongs, or forceps. Plastic ware should be substituted
for glassware whenever possible.
e. Perform all procedures to minimize the creation of splashes and/or aerosols.
11. Decontaminate work surfaces after completion of work and after any spill or splash of
potentially infectious material with appropriate disinfectant.
12. Decontaminate all cultures, stocks, and other potentially infectious materials before
disposal using an effective method. Depending on where the decontamination will be
performed, the following methods should be used prior to transport. Materials to be
decontaminated outside of the immediate laboratory must be placed in a durable, leak
proof container and secured for transport.
13. Materials to be removed from the facility for decontamination must be packed in
accordance with applicable local, state, and federal regulations.
14. A sign incorporating the universal biohazard symbol must be posted at the entrance to
the laboratory when infectious agents are present. The sign may include the name of
the agent(s) in use, and the name and phone number of the laboratory supervisor or
other responsible personnel.
Requirements for Safety Equipment
1. Properly maintained biosafety cabinets, other appropriate personal protective
equipment, or other physical containment devices must be used whenever:
a. Procedures with a potential for creating infectious aerosols or splashes are
conducted. These may include pipetting, centrifuging, grinding, blending,
shaking, mixing, sonicating, opening containers of infectious materials,
inoculating animals intranasally, and harvesting infected tissues from animals or
eggs.
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2.
3.

4.

5.

6.

b. High concentrations or large volumes of infectious agents are used.
c. Such materials may be centrifuged in the open laboratory using sealed rotor
heads or centrifuge safety cups.
Protective laboratory coats, gowns, smocks, or uniforms designated for laboratory use
must be worn while working with hazardous materials.
Remove protective clothing before leaving for non-laboratory areas, e.g., cafeteria,
library, and administrative offices). Dispose of protective clothing appropriately, or
deposit it for laundering by the institution. It is recommended that laboratory clothing not
be taken home.
Eye and face protection (goggles, mask, face shield or other splatter guard) is used for
anticipated splashes or sprays of infectious or other hazardous materials when the
microorganisms must be handled outside the BSC or containment device. Eye and face
protection must be disposed of with other contaminated laboratory waste or
decontaminated before reuse. Persons who wear contact lenses in laboratories should
also wear eye protection.
Gloves must be worn to protect hands from exposure to hazardous materials. Glove
selection should be based on an appropriate risk assessment. Alternatives to latex
gloves should be available. Gloves must not be worn outside the laboratory. In addition,
BSL-2 laboratory workers should:
a. Change gloves when contaminated, glove integrity is compromised, or when
otherwise necessary.
b. Remove gloves and wash hands when work with hazardous materials has been
completed and before leaving the laboratory.
c. Do not wash or reuse disposable gloves. Dispose of used gloves with other
contaminated laboratory waste. Hand washing protocols must be rigorously
followed.
Vacuum lines should be protected with liquid disinfectant traps.
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MEDICAL WASTE MANAGEMENT
The Regulated Medical Wastes subchapter 3A (N.J.A.C. 7:26-3A.6) defines Regulated Medical
Waste as solid waste that meets both the process definition and the classification definitions
listed below.
Regulated Medical Waste (RWM) is any solid waste generated from one of the following
processes: the diagnosis, treatment or immunization of humans or animals; research
pertaining to the diagnosis, treatment or immunization of humans or animals; or the production
or testing of biologicals. It must also belong to one of the classes listed below.
Class 1 - Cultures and Stocks
Cultures and stocks of infectious agents and associated biologicals, including: cultures from
medical and pathological laboratories; cultures and stocks of infectious agents from research
and industrial laboratories; wastes from the production of biologicals; discarded live and
attenuated vaccines; and culture dishes and devices used to transfer, inoculate, and mix
cultures.
Liquid Waste Disposal: It is expected that laboratories will disinfect all liquid cultures and
stocks before drain disposal. In general, the organisms in use at Kean are susceptible to a 1%
chlorine solution. In practice, this means that household bleach (a 5% solution of sodium
hypochloride) should be added to the liquid culture at the rate of 1 part bleach to 4 parts liquid
to be disinfected. Wait at least 20 minutes, and then dispose of the liquid down the drain.
The lab may also disinfect liquids by autoclaving them at 121oC for at least 30 minutes,
followed by drain disposal.
Solid Waste Disposal: Solid wastes should be placed in unsealed autoclave bags and
autoclaved at 121oC for at least 30 minutes. The autoclave bags can be sealed and then
placed in the red bag waste for disposal.
Class 2 - Pathological Wastes
Human pathological wastes, including tissues, organs, and body parts and body fluids that are
removed during surgery or autopsy, or other medical procedures, and specimens of body
fluids and their containers. These materials are not generally found on the Kean campus.
Contact EHS for assistance in disposal.
Class 3 - Human Blood and Blood Products
Liquid waste human blood; blood; items saturated and/or dripping with human blood; or items
that or items that were saturated and/or dripping with human blood that are now caked with
dried human blood; including serum, plasma, and other blood components, and their
containers, which were used or intended for use in either patient care, testing and laboratory
analysis or the development of pharmaceuticals. Intravenous bags (only if they have come into
contact with blood or other regulated body fluid), soft plastic pipettes and plastic blood vials are
also included in this category.
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Disposal: All materials that are dripping or saturated with human blood or other body fluids
shall be placed in red bags. Notify EHS for assistance with disposal.
Class 4 – Sharps
Sharps that were used in animal or human patient care or treatment or in medical research, or
industrial laboratories, including sharp, or potentially sharp if broken, items such as, but not
limited to, hypodermic needles, all syringes to which a needle can be attached (with or without
the attached needle) and their components, including those from manufacturing research,
manufacturing and marketing, pasteur pipettes, scalpel blades, blood vials, carpules, needles
with attached tubing, acupuncture needles and culture dishes (regardless of presence of
infectious agents). Also included are other types of broken or unbroken glassware that were in
contact with infectious agents, such as used slides and cover slips.
Disposal: All sharps, including syringes, needles, razor and scalpel blades, and microscope
slides and slips must be discarded into red plastic biohazard containers (“sharps” containers).
This is required even if the sharp is unused. Also, pipettes, pipette tips, culture dishes, as well
as other glass or plastic items that have been exposed to potentially infectious biological
materials must also be placed in a sharps container for disposal.
Class 5 - Animal Waste/Carcasses
Contaminated animal carcasses, body parts, and bedding of animals that were known to have
been exposed to infectious agents during research (including research in veterinary hospitals),
production of biologicals, or testing of pharmaceuticals.
Disposal: Kean generates animal carcasses as a result of classroom activities in the biological
sciences. However, the carcasses do not meet the definition of animal waste under the
Regulated Medical Regulations. Preserved carcasses should be double-bagged, and placed
in Bruce B-120M or STEM 1-26 for disposal. EHS will dispose of preserved carcasses as
hazardous waste. Non-preserved carcasses should be double-bagged in and placed in Bruce
B-120M or STEM 1-26 for disposal. EHS will dispose of non-preserved carcasses as overclassified medical waste.
Class 6 - Isolation Wastes
Biological waste and discarded materials contaminated with blood, excretion, exudates, or
secretions from humans who are isolated to protect others from certain highly communicable
diseases, or isolated animals known to be infected with highly communicable diseases.
These materials are not generally found on the Kean campus. Contact EHS for assistance in
disposal.
Class 7 - Unused Sharps
The following unused, discarded sharps that were intended to be used: hypodermic needles,
suture needles, syringes, and scalpel blades.
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Disposal: All sharps, including syringes, needles, razor and scalpel blades, and microscope
slides and slips must be discarded into red plastic biohazard containers (“sharps” containers).
This is required even if the sharp is unused. Also, pipettes, pipette tips, culture dishes, as well
as other glass or plastic items that have been exposed to potentially infectious biological
materials must also be placed in a sharps container for disposal.
Container Handling Procedures
Containers of medical waste shall be:



Maintained upright throughout use; and
Replaced routinely and not be allowed to overfill.

When moving containers of contaminated sharps from the area of use, the containers shall be:





Closed immediately prior to removal or replacement to prevent spillage or protrusion of
contents during handling, storage, transport, or shipping;
Placed in a secondary container if leakage is possible. The second container shall be:
o Closable;
o Constructed to contain all contents and prevent leakage during handling, storage,
transport, or shipping; and
o Labeled or color-coded according.
Reusable containers shall not be opened, emptied, or cleaned manually or in any other
manner which would expose employees to the risk of percutaneous injury.

Storage Areas for Medical Waste
Bruce and Science: Medical Waste should be placed in room B120M for disposal.
STEM: Medical Waste should be placed in room 1-26 for disposal.
Athletics Department: Medical waste is kept in a locked room in the Trainer’s area at the
D’Angola Gymnasium, and is removed by EHS as needed.
Student Health Services: Medical waste is kept in kept in a locked room in the Health Services
area, and is removed by EHS as needed.
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DEFINITIONS AND ABBREVIATIONS
BBP means bloodborne pathogen(s)
Blood means human blood, human blood components, and products made from human blood.
Bloodborne Pathogens means pathogenic microorganisms that are present in human blood and can cause
disease in humans. These pathogens include, but are not limited to, hepatitis B virus (HBV) and human
immunodeficiency virus (HIV).
Clinical Laboratory means a workplace where diagnostic or other screening procedures are performed on blood
or other potentially infectious materials.
Contaminated means the presence or the reasonably anticipated presence of blood or other potentially infectious
materials on an item or surface.
Contaminated Laundry means laundry which has been soiled with blood or other potentially infectious materials
or may contain sharps.
Contaminated Sharps means any contaminated object that can penetrate the skin including, but not limited to,
needles, scalpels, broken glass, broken capillary tubes, and exposed ends of dental wires.
CPR means Cardio-Pulmonary Resuscitation
Decontamination means the use of physical or chemical means to remove, inactivate, or destroy bloodborne
pathogens on a surface or item to the point where they are no longer capable of transmitting infectious particles
and the surface or item is rendered safe for handling, use, or disposal.
ECP means Exposure Control Plan
EHS means the Office of Environmental Safety and Health at Kean University
Engineering Controls means controls (e.g., sharps disposal containers, self-sheathing needles, safer medical
devices, such as sharps with engineered sharps injury protections and needleless systems) that isolate or remove
the bloodborne pathogens hazard from the workplace.
Exposure Incident means a specific eye, mouth, other mucous membrane, non-intact skin, or parenteral contact
with blood or other potentially infectious materials that results from the performance of an employee's duties.
FCP means the Office of Facilities and Campus Planning at Kean University
Handwashing Facilities means a facility providing an adequate supply of running potable water, soap, and
single-use towels or air-drying machines.
HB means Hepatitis B.
HBV means hepatitis B virus.
HCP means Health Care Provider
HIV means human immunodeficiency virus.
Licensed Healthcare Professional is a person whose legally permitted scope of practice allows him or her to
independently perform the activities required by paragraph (f) Hepatitis B Vaccination and Post-exposure
Evaluation and Follow-up.
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Needleless systems means a device that does not use needles for:
(1) The collection of bodily fluids or withdrawal of body fluids after initial venous or arterial access is established;
(2) The administration of medication or fluids; or (3) Any other procedure involving the potential for occupational
exposure to bloodborne pathogens due to percutaneous injuries from contaminated sharps.
NIOSH means the National Institute for Occupational Safety and Health
Occupational Exposure means reasonably anticipated skin, eye, mucous membrane, or parenteral contact with
blood or other potentially infectious materials that may result from the performance of an employee's duties.
OPIM see “Other Potentially Infectious Materials”
Other Potentially Infectious Materials (OPIM) means (1) The following human body fluids: semen, vaginal
secretions, cerebrospinal fluid, synovial fluid, pleural fluid, pericardial fluid, peritoneal fluid, amniotic fluid, saliva in
dental procedures, any body fluid that is visibly contaminated with blood, and all body fluids in situations where it
is difficult or impossible to differentiate between body fluids; (2) Any unfixed tissue or organ (other than intact skin)
from a human (living or dead); and (3) HIV-containing cell or tissue cultures, organ cultures, and HIV- or HBVcontaining culture medium or other solutions; and blood, organs, or other tissues from experimental animals
infected with HIV or HBV.
Parenteral means piercing mucous membranes or the skin barrier through such events as needlesticks, human
bites, cuts, and abrasions.
Personal Protective Equipment is specialized clothing or equipment worn by an employee for protection against
a hazard. General work clothes (e.g., uniforms, pants, shirts or blouses) not intended to function as protection
against a hazard are not considered to be personal protective equipment.
PPE see “Personal Protective Equipment “
Red Bag means a red plastic bag that is used for the disposal of ‘non-sharp’ and potentially infectious
biohazardous waste.
Regulated Medical Waste (RMW) means liquid or semi-liquid blood or other potentially infectious materials;
contaminated items that would release blood or other potentially infectious materials in a liquid or semi-liquid state
if compressed; items that are caked with dried blood or other potentially infectious materials and are capable of
releasing these materials during handling; contaminated sharps; and pathological and microbiological wastes
containing blood or other potentially infectious materials.
Research Laboratory means a laboratory producing or using research-laboratory-scale amounts of HIV or HBV.
Research laboratories may produce high concentrations of HIV or HBV but not in the volume found in production
facilities.
RMW see “Regulated Medical Waste”
Sharps with engineered sharps injury protections means a non-needle sharp or a needle device used for
withdrawing body fluids, accessing a vein or artery, or administering medications or other fluids, with a built-in
safety feature or mechanism that effectively reduces the risk of an exposure incident.
Source Individual means any individual, living or dead, whose blood or other potentially infectious materials may
be a source of occupational exposure to the employee. Examples include, but are not limited to, hospital and
clinic patients; clients in institutions for the developmentally disabled; trauma victims; clients of drug and alcohol
treatment facilities; residents of hospices and nursing homes; human remains; and individuals who donate or sell
blood or blood components.
Sterilize means the use of a physical or chemical procedure to destroy all microbial life including highly resistant
bacterial endospores.
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Universal Precautions is an approach to infection control. According to the concept of Universal Precautions, all
human blood and certain human body fluids are treated as if known to be infectious for HIV, HBV, and other
bloodborne pathogens.
Work Practice Controls means controls that reduce the likelihood of exposure by altering the manner in which a
task is performed (e.g., prohibiting recapping of needles by a two-handed technique).
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FULL TEXT OF 29 CFR 1910.1030 BLOODBORNE PATHOGENS
(a) Scope and Application. This section applies to all occupational exposure to blood or other potentially infectious materials as defined by
paragraph (b) of this section.
(b) Definitions. For purposes of this section, the following shall apply:
Assistant Secretary means the Assistant Secretary of Labor for Occupational Safety and Health, or designated representative.
Blood means human blood, human blood components, and products made from human blood.
Bloodborne Pathogens means pathogenic microorganisms that are present in human blood and can cause disease in humans. These
pathogens include, but are not limited to, hepatitis B virus (HBV) and human immunodeficiency virus (HIV).
Clinical Laboratory means a workplace where diagnostic or other screening procedures are performed on blood or other potentially
infectious materials.
Contaminated means the presence or the reasonably anticipated presence of blood or other potentially infectious materials on an item or
surface.
Contaminated Laundry means laundry which has been soiled with blood or other potentially infectious materials or may contain sharps.
Contaminated Sharps means any contaminated object that can penetrate the skin including, but not limited to, needles, scalpels, broken
glass, broken capillary tubes, and exposed ends of dental wires.
Decontamination means the use of physical or chemical means to remove, inactivate, or destroy bloodborne pathogens on a surface or item
to the point where they are no longer capable of transmitting infectious particles and the surface or item is rendered safe for handling, use, or
disposal.
Director means the Director of the National Institute for Occupational Safety and Health, U.S. Department of Health and Human Services, or
designated representative.
Engineering Controls means controls (e.g., sharps disposal containers, self-sheathing needles, safer medical devices, such as sharps with
engineered sharps injury protections and needleless systems) that isolate or remove the bloodborne pathogens hazard from the workplace.
Exposure Incident means a specific eye, mouth, other mucous membrane, non-intact skin, or parenteral contact with blood or other
potentially infectious materials that results from the performance of an employee's duties.
Handwashing Facilities means a facility providing an adequate supply of running potable water, soap and single use towels or hot air drying
machines.
Licensed Healthcare Professional is a person whose legally permitted scope of practice allows him or her to independently perform the
activities required by paragraph (f) Hepatitis B Vaccination and Post-exposure Evaluation and Follow-up.
HBV means hepatitis B virus.
HIV means human immunodeficiency virus.
Needleless Systems means a device that does not use needles for (1) the collection of bodily fluids or withdrawal of body fluids after initial
venous or arterial access is established; (2) the administration of medication or fluids; or (3) any other procedure involving the potential for
occupational exposure to bloodborne pathogens due to percutaneous injuries from contaminated sharps.
Occupational Exposure means reasonably anticipated skin, eye, mucous membrane, or parenteral contact with blood or other potentially
infectious materials that may result from the performance of an employee's duties.
Other Potentially Infectious Materials means (1) The following human body fluids: semen, vaginal secretions, cerebrospinal fluid, synovial
fluid, pleural fluid, pericardial fluid, peritoneal fluid, amniotic fluid, saliva in dental procedures, any body fluid that is visibly contaminated with
blood, and all body fluids in situations where it is difficult or impossible to differentiate between body fluids; (2) Any unfixed tissue or organ
(other than intact skin) from a human (living or dead); and (3) HIV-containing cell or tissue cultures, organ cultures, and HIV- or HBVcontaining culture medium or other solutions; and blood, organs, or other tissues from experimental animals infected with HIV or HBV.
Parenteral means piercing mucous membranes or the skin barrier through such events as needlesticks, human bites, cuts, and abrasions.
Personal Protective Equipment is specialized clothing or equipment worn by an employee for protection against a hazard. General work
clothes (e.g., uniforms, pants, shirts or blouses) not intended to function as protection against a hazard are not considered to be personal
protective equipment.
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Production Facility means a facility engaged in industrial-scale, large-volume or high concentration production of HIV or HBV.
Regulated Waste means liquid or semi-liquid blood or other potentially infectious materials; contaminated items that would release blood or
other potentially infectious materials in a liquid or semi-liquid state if compressed; items that are caked with dried blood or other potentially
infectious materials and are capable of releasing these materials during handling; contaminated sharps; and pathological and microbiological
wastes containing blood or other potentially infectious materials.
Research Laboratory means a laboratory producing or using research-laboratory-scale amounts of HIV or HBV. Research laboratories may
produce high concentrations of HIV or HBV but not in the volume found in production facilities.
Sharps with Engineered Sharps Injury Protections means a nonneedle sharp or a needle device used for withdrawing body fluids,
accessing a vein or artery, or administering medications or other fluids, with a built-in safety feature or mechanism that effectively reduces the
risk of an exposure incident.
Source Individual means any individual, living or dead, whose blood or other potentially infectious materials may be a source of occupational
exposure to the employee. Examples include, but are not limited to, hospital and clinic patients; clients in institutions for the developmentally
disabled; trauma victims; clients of drug and alcohol treatment facilities; residents of hospices and nursing homes; human remains; and
individuals who donate or sell blood or blood components.
Sterilize means the use of a physical or chemical procedure to destroy all microbial life including highly resistant bacterial endospores.
Universal Precautions is an approach to infection control. According to the concept of Universal Precautions, all human blood and certain
human body fluids are treated as if known to be infectious for HIV, HBV, and other bloodborne pathogens.
Work Practice Controls means controls that reduce the likelihood of exposure by altering the manner in which a task is performed (e.g.,
prohibiting recapping of needles by a two-handed technique).
(c) Exposure Control (c)(1) Exposure Control Plan.
(c)(1)(i) Each employer having an employee(s) with occupational exposure as defined by paragraph (b) of this section shall establish a written
Exposure Control Plan designed to eliminate or minimize employee exposure.
(c)(1)(ii) The Exposure Control Plan shall contain at least the following elements:
(c)(1)(ii)(A) The exposure determination required by paragraph (c)(2),
(c)(1)(ii)(B) The schedule and method of implementation for paragraphs (d) Methods of Compliance, (e) HIV and HBV Research Laboratories
and Production Facilities, (f) Hepatitis B Vaccination and Post-Exposure Evaluation and Follow-up, (g) Communication of Hazards to
Employees, and (h) Recordkeeping, of this standard, and
(c)(1)(ii)(C) The procedure for the evaluation of circumstances surrounding exposure incidents as required by paragraph (f)(3)(i) of this
standard.
(c)(1)(iii) Each employer shall ensure that a copy of the Exposure Control Plan is accessible to employees in accordance with 29 CFR
1910.1020(e).
(c)(1)(iv) The Exposure Control Plan shall be reviewed and updated at least annually and whenever necessary to reflect new or modified tasks
and procedures which affect occupational exposure and to reflect new or revised employee positions with occupational exposure. The review
and update of such plans shall also:
(c)(1)(iv)(A) reflect changes in technology that eliminate or reduce exposure to bloodborne pathogens; and
(c)(1)(iv)(B) document annually consideration and implementation of appropriate commercially available and effective safer medical devices
designed to eliminate or minimize occupational exposure.
(c)(1)(v) An employer, who is required to establish an Exposure Control Plan shall solicit input from non-managerial employees responsible for
direct patient care who are potentially exposed to injuries from contaminated sharps in the identification, evaluation, and selection of effective
engineering and work practice controls and shall document the solicitation in the Exposure Control Plan.
(c)(1)(vi) The Exposure Control Plan shall be made available to the Assistant Secretary and the Director upon request for examination and
copying.
(c)(2) Exposure Determination.
(c)(2)(i) Each employer who has an employee(s) with occupational exposure as defined by paragraph (b) of this section shall prepare an
exposure determination. This exposure determination shall contain the following:
(c)(2)(i)(A) A list of all job classifications in which all employees in those job classifications have occupational exposure;
(c)(2)(i)(B) A list of job classifications in which some employees have occupational exposure, and
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(c)(2)(i)(C) A list of all tasks and procedures or groups of closely related task and procedures in which occupational exposure occurs and that
are performed by employees in job classifications listed in accordance with the provisions of paragraph (c)(2)(i)(B) of this standard.
(c)(2)(ii) This exposure determination shall be made without regard to the use of personal protective equipment.
(d) Methods of Compliance (d)(1) General. Universal precautions shall be observed to prevent contact with blood or other potentially infectious materials. Under
circumstances in which differentiation between body fluid types is difficult or impossible, all body fluids shall be considered potentially
infectious materials.
(d)(2) Engineering and Work Practice Controls.
(d)(2)(i) Engineering and work practice controls shall be used to eliminate or minimize employee exposure. Where occupational exposure
remains after institution of these controls, personal protective equipment shall also be used.
(d)(2)(ii) Engineering controls shall be examined and maintained or replaced on a regular schedule to ensure their effectiveness.
(d)(2)(iii) Employers shall provide handwashing facilities which are readily accessible to employees.
(d)(2)(iv) When provision of handwashing facilities is not feasible, the employer shall provide either an appropriate antiseptic hand cleanser in
conjunction with clean cloth/paper towels or antiseptic towelettes. When antiseptic hand cleansers or towelettes are used, hands shall be
washed with soap and running water as soon as feasible.
(d)(2)(v) Employers shall ensure that employees wash their hands immediately or as soon as feasible after removal of gloves or other
personal protective equipment.
(d)(2)(vi) Employers shall ensure that employees wash hands and any other skin with soap and water, or flush mucous membranes with water
immediately or as soon as feasible following contact of such body areas with blood or other potentially infectious materials.
(d)(2)(vii) Contaminated needles and other contaminated sharps shall not be bent, recapped, or removed except as noted in paragraphs
(d)(2)(vii)(A) and (d)(2)(vii)(B) below. Shearing or breaking of contaminated needles is prohibited.
(d)(2)(vii)(A) Contaminated needles and other contaminated sharps shall not be bent, recapped or removed unless the employer can
demonstrate that no alternative is feasible or that such action is required by a specific medical or dental procedure.
(d)(2)(vii)(B) Such bending, recapping or needle removal must be accomplished through the use of a mechanical device or a one-handed
technique.
(d)(2)(viii) Immediately or as soon as possible after use, contaminated reusable sharps shall be placed in appropriate containers until properly
reprocessed. These containers shall be:
(d)(2)(viii)(A) puncture resistant;
(d)(2)(viii)(B) labeled or color-coded in accordance with this standard;
(d)(2)(viii)(C) leakproof on the sides and bottom; and
(d)(2)(viii)(D) in accordance with the requirements set forth in paragraph (d)(4)(ii)(E) for reusable sharps.
(d)(2)(ix) Eating, drinking, smoking, applying cosmetics or lip balm, and handling contact lenses are prohibited in work areas where there is a
reasonable likelihood of occupational exposure.
(d)(2)(x) Food and drink shall not be kept in refrigerators, freezers, shelves, cabinets or on countertops or benchtops where blood or other
potentially infectious materials are present.
(d)(2)(xi) All procedures involving blood or other potentially infectious materials shall be performed in such a manner as to minimize splashing,
spraying, spattering, and generation of droplets of these substances.
(d)(2)(xii) Mouth pipetting/suctioning of blood or other potentially infectious materials is prohibited.
(d)(2)(xiii) Specimens of blood or other potentially infectious materials shall be placed in a container which prevents leakage during collection,
handling, processing, storage, transport, or shipping.
(d)(2)(xiii)(A) The container for storage, transport, or shipping shall be labeled or color-coded according to paragraph (g)(1)(i) and closed prior
to being stored, transported, or shipped. When a facility utilizes Universal Precautions in the handling of all specimens, the labeling/colorcoding of specimens is not necessary provided containers are recognizable as containing specimens. This exemption only applies while such
specimens/containers remain within the facility. Labeling or color-coding in accordance with paragraph (g)(1)(i) is required when such
specimens/containers leave the facility.
(d)(2)(xiii)(B) If outside contamination of the primary container occurs, the primary container shall be placed within a second container which
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prevents leakage during handling, processing, storage, transport, or shipping and is labeled or color-coded according to the requirements of
this standard.
(d)(2)(xiii)(C) If the specimen could puncture the primary container, the primary container shall be placed within a secondary container which is
puncture-resistant in addition to the above characteristics.
(d)(2)(xiv) Equipment which may become contaminated with blood or other potentially infectious materials shall be examined prior to servicing
or shipping and shall be decontaminated as necessary, unless the employer can demonstrate that decontamination of such equipment or
portions of such equipment is not feasible.
(d)(2)(xiv)(A) A readily observable label in accordance with paragraph (g)(1)(i)(H) shall be attached to the equipment stating which portions
remain contaminated.
(d)(2)(xiv)(B) The employer shall ensure that this information is conveyed to all affected employees, the servicing representative, and/or the
manufacturer, as appropriate, prior to handling, servicing, or shipping so that appropriate precautions will be taken.
(d)(3) Personal Protective Equipment (d)(3)(i) Provision. When there is occupational exposure, the employer shall provide, at no cost to the employee, appropriate personal
protective equipment such as, but not limited to, gloves, gowns, laboratory coats, face shields or masks and eye protection, and mouthpieces,
resuscitation bags, pocket masks, or other ventilation devices. Personal protective equipment will be considered "appropriate" only if it does
not permit blood or other potentially infectious materials to pass through to or reach the employee's work clothes, street clothes,
undergarments, skin, eyes, mouth, or other mucous membranes under normal conditions of use and for the duration of time which the
protective equipment will be used.
(d)(3)(ii) Use. The employer shall ensure that the employee uses appropriate personal protective equipment unless the employer shows that
the employee temporarily and briefly declined to use personal protective equipment when, under rare and extraordinary circumstances, it was
the employee's professional judgment that in the specific instance its use would have prevented the delivery of health care or public safety
services or would have posed an increased hazard to the safety of the worker or co-worker. When the employee makes this judgement, the
circumstances shall be investigated and documented in order to determine whether changes can be instituted to prevent such occurrences in
the future.
(d)(3)(iii) Accessibility. The employer shall ensure that appropriate personal protective equipment in the appropriate sizes is readily
accessible at the worksite or is issued to employees. Hypoallergenic gloves, glove liners, powderless gloves, or other similar alternatives shall
be readily accessible to those employees who are allergic to the gloves normally provided.
(d)(3)(iv) Cleaning, Laundering, and Disposal. The employer shall clean, launder, and dispose of personal protective equipment required by
paragraphs (d) and (e) of this standard, at no cost to the employee.
(d)(3)(v) Repair and Replacement. The employer shall repair or replace personal protective equipment as needed to maintain its
effectiveness, at no cost to the employee.
(d)(3)(vi) If a garment(s) is penetrated by blood or other potentially infectious materials, the garment(s) shall be removed immediately or as
soon as feasible.
(d)(3)(vii) All personal protective equipment shall be removed prior to leaving the work area.
(d)(3)(viii) When personal protective equipment is removed it shall be placed in an appropriately designated area or container for storage,
washing, decontamination or disposal.
(d)(3)(ix) Gloves. Gloves shall be worn when it can be reasonably anticipated that the employee may have hand contact with blood, other
potentially infectious materials, mucous membranes, and non-intact skin; when performing vascular access procedures except as specified in
paragraph (d)(3)(ix)(D); and when handling or touching contaminated items or surfaces.
(d)(3)(ix)(A) Disposable (single use) gloves such as surgical or examination gloves, shall be replaced as soon as practical when contaminated
or as soon as feasible if they are torn, punctured, or when their ability to function as a barrier is compromised.
(d)(3)(ix)(B) Disposable (single use) gloves shall not be washed or decontaminated for re-use.
(d)(3)(ix)(C) Utility gloves may be decontaminated for re-use if the integrity of the glove is not compromised. However, they must be discarded
if they are cracked, peeling, torn, punctured, or exhibit other signs of deterioration or when their ability to function as a barrier is compromised.
(d)(3)(ix)(D) If an employer in a volunteer blood donation center judges that routine gloving for all phlebotomies is not necessary then the
employer shall:
(d)(3)(ix)(D)(1) Periodically reevaluate this policy;
(d)(3)(ix)(D)(2) Make gloves available to all employees who wish to use them for phlebotomy;
(d)(3)(ix)(D)(3) Not discourage the use of gloves for phlebotomy; and
(d)(3)(ix)(D)(4) Require that gloves be used for phlebotomy in the following circumstances:
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(d)(3)(ix)(D)(4)(i) When the employee has cuts, scratches, or other breaks in his or her skin;
(d)(3)(ix)(D)(4)(ii) When the employee judges that hand contamination with blood may occur, for example, when performing phlebotomy on an
uncooperative source individual; and
(d)(3)(ix)(D)(4)(iii) When the employee is receiving training in phlebotomy.
(d)(3)(x) Masks, Eye Protection, and Face Shields. Masks in combination with eye protection devices, such as goggles or glasses with solid
side shields, or chin-length face shields, shall be worn whenever splashes, spray, spatter, or droplets of blood or other potentially infectious
materials may be generated and eye, nose, or mouth contamination can be reasonably anticipated.
(d)(3)(xi) Gowns, Aprons, and Other Protective Body Clothing. Appropriate protective clothing such as, but not limited to, gowns, aprons,
lab coats, clinic jackets, or similar outer garments shall be worn in occupational exposure situations. The type and characteristics will depend
upon the task and degree of exposure anticipated.
(d)(3)(xii) Surgical caps or hoods and/or shoe covers or boots shall be worn in instances when gross contamination can reasonably be
anticipated (e.g., autopsies, orthopaedic surgery).
(d)(4) Housekeeping (d)(4)(i) General. Employers shall ensure that the worksite is maintained in a clean and sanitary condition. The employer shall determine and
implement an appropriate written schedule for cleaning and method of decontamination based upon the location within the facility, type of
surface to be cleaned, type of soil present, and tasks or procedures being performed in the area.
(d)(4)(ii) All equipment and environmental and working surfaces shall be cleaned and decontaminated after contact with blood or other
potentially infectious materials.
(d)(4)(ii)(A) Contaminated work surfaces shall be decontaminated with an appropriate disinfectant after completion of procedures; immediately
or as soon as feasible when surfaces are overtly contaminated or after any spill of blood or other potentially infectious materials; and at the
end of the work shift if the surface may have become contaminated since the last cleaning.
(d)(4)(ii)(B) Protective coverings, such as plastic wrap, aluminum foil, or imperviously-backed absorbent paper used to cover equipment and
environmental surfaces, shall be removed and replaced as soon as feasible when they become overtly contaminated or at the end of the
workshift if they may have become contaminated during the shift.
(d)(4)(ii)(C) All bins, pails, cans, and similar receptacles intended for reuse which have a reasonable likelihood for becoming contaminated
with blood or other potentially infectious materials shall be inspected and decontaminated on a regularly scheduled basis and cleaned and
decontaminated immediately or as soon as feasible upon visible contamination.
(d)(4)(ii)(D) Broken glassware which may be contaminated shall not be picked up directly with the hands. It shall be cleaned up using
mechanical means, such as a brush and dust pan, tongs, or forceps.
(d)(4)(ii)(E) Reusable sharps that are contaminated with blood or other potentially infectious materials shall not be stored or processed in a
manner that requires employees to reach by hand into the containers where these sharps have been placed.
(d)(4)(iii) Regulated Waste--(d)(4)(iii)(A) Contaminated Sharps Discarding and Containment.
(d)(4)(iii)(A)(1) Contaminated sharps shall be discarded immediately or as soon as feasible in containers that are:
(d)(4)(iii)(A)(1)(i) Closable;
(d)(4)(iii)(A)(1)(ii) Puncture resistant;
(d)(4)(iii)(A)(1)(iii) Leakproof on sides and bottom; and
(d)(4)(iii)(A)(1)(iv) Labeled or color-coded in accordance with paragraph (g)(1)(i) of this standard.
(d)(4)(iii)(A)(2) During use, containers for contaminated sharps shall be:
(d)(4)(iii)(A)(2)(i) Easily accessible to personnel and located as close as is feasible to the immediate area where sharps are used or can be
reasonably anticipated to be found (e.g., laundries);
(d)(4)(iii)(A)(2)(ii) Maintained upright throughout use; and
(d)(4)(iii)(A)(2)(iii) Replaced routinely and not be allowed to overfill.
(d)(4)(iii)(A)(3) When moving containers of contaminated sharps from the area of use, the containers shall be:
(d)(4)(iii)(A)(3)(i) Closed immediately prior to removal or replacement to prevent spillage or protrusion of contents during handling, storage,
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transport, or shipping;
(d)(4)(iii)(A)(3)(ii) Placed in a secondary container if leakage is possible. The second container shall be:
(d)(4)(iii)(A)(3)(ii)(A) Closable;
(d)(4)(iii)(A)(3)(ii)(B) Constructed to contain all contents and prevent leakage during handling, storage, transport, or shipping; and
(d)(4)(iii)(A)(3)(ii)(C) Labeled or color-coded according to paragraph (g)(1)(i) of this standard.
(d)(4)(iii)(A)(4) Reusable containers shall not be opened, emptied, or cleaned manually or in any other manner which would expose
employees to the risk of percutaneous injury.
(d)(4)(iii)(B) Other Regulated Waste Containment (d)(4)(iii)(B)(1) Regulated waste shall be placed in containers which are:
(d)(4)(iii)(B)(1)(i) Closable;
(d)(4)(iii)(B)(1)(ii) Constructed to contain all contents and prevent leakage of fluids during handling, storage, transport or shipping;
(d)(4)(iii)(B)(1)(iii) Labeled or color-coded in accordance with paragraph (g)(1)(i) this standard; and
(d)(4)(iii)(B)(1)(iv) Closed prior to removal to prevent spillage or protrusion of contents during handling, storage, transport, or shipping.
(d)(4)(iii)(B)(2) If outside contamination of the regulated waste container occurs, it shall be placed in a second container. The second container
shall be:
(d)(4)(iii)(B)(2)(i) Closable;
(d)(4)(iii)(B)(2)(ii) Constructed to contain all contents and prevent leakage of fluids during handling, storage, transport or shipping;
(d)(4)(iii)(B)(2)(iii) Labeled or color-coded in accordance with paragraph (g)(1)(i) of this standard; and
(d)(4)(iii)(B)(2)(iv) Closed prior to removal to prevent spillage or protrusion of contents during handling, storage, transport, or shipping.
(d)(4)(iii)(C) Disposal of all regulated waste shall be in accordance with applicable regulations of the United States, States and Territories, and
political subdivisions of States and Territories.
(d)(4)(iv) Laundry.
(d)(4)(iv)(A) Contaminated laundry shall be handled as little as possible with a minimum of agitation.
(d)(4)(iv)(A)(1) Contaminated laundry shall be bagged or containerized at the location where it was used and shall not be sorted or rinsed in
the location of use.
(d)(4)(iv)(A)(2) Contaminated laundry shall be placed and transported in bags or containers labeled or color-coded in accordance with
paragraph (g)(1)(i) of this standard. When a facility utilizes Universal Precautions in the handling of all soiled laundry, alternative labeling or
color-coding is sufficient if it permits all employees to recognize the containers as requiring compliance with Universal Precautions.
(d)(4)(iv)(A)(3) Whenever contaminated laundry is wet and presents a reasonable likelihood of soak-through of or leakage from the bag or
container, the laundry shall be placed and transported in bags or containers which prevent soak-through and/or leakage of fluids to the
exterior.
(d)(4)(iv)(B) The employer shall ensure that employees who have contact with contaminated laundry wear protective gloves and other
appropriate personal protective equipment.
(d)(4)(iv)(C) When a facility ships contaminated laundry off-site to a second facility which does not utilize Universal Precautions in the handling
of all laundry, the facility generating the contaminated laundry must place such laundry in bags or containers which are labeled or color-coded
in accordance with paragraph (g)(1)(i).
(e) HIV and HBV Research Laboratories and Production Facilities.
(e)(1) This paragraph applies to research laboratories and production facilities engaged in the culture, production, concentration,
experimentation, and manipulation of HIV and HBV. It does not apply to clinical or diagnostic laboratories engaged solely in the analysis of
blood, tissues, or organs. These requirements apply in addition to the other requirements of the standard.
(e)(2) Research laboratories and production facilities shall meet the following criteria:
(e)(2)(i) Standard Microbiological Practices. All regulated waste shall either be incinerated or decontaminated by a method such as
autoclaving known to effectively destroy bloodborne pathogens.
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(e)(2)(ii) Special Practices.
(e)(2)(ii)(A) Laboratory doors shall be kept closed when work involving HIV or HBV is in progress.
(e)(2)(ii)(B) Contaminated materials that are to be decontaminated at a site away from the work area shall be placed in a durable, leakproof,
labeled or color-coded container that is closed before being removed from the work area.
(e)(2)(ii)(C) Access to the work area shall be limited to authorized persons. Written policies and procedures shall be established whereby only
persons who have been advised of the potential biohazard, who meet any specific entry requirements, and who comply with all entry and exit
procedures shall be allowed to enter the work areas and animal rooms.
(e)(2)(ii)(D) When other potentially infectious materials or infected animals are present in the work area or containment module, a hazard
warning sign incorporating the universal biohazard symbol shall be posted on all access doors. The hazard warning sign shall comply with
paragraph (g)(1)(ii) of this standard.
(e)(2)(ii)(E) All activities involving other potentially infectious materials shall be conducted in biological safety cabinets or other physicalcontainment devices within the containment module. No work with these other potentially infectious materials shall be conducted on the open
bench.
(e)(2)(ii)(F) Laboratory coats, gowns, smocks, uniforms, or other appropriate protective clothing shall be used in the work area and animal
rooms. Protective clothing shall not be worn outside of the work area and shall be decontaminated before being laundered.
(e)(2)(ii)(G) Special care shall be taken to avoid skin contact with other potentially infectious materials. Gloves shall be worn when handling
infected animals and when making hand contact with other potentially infectious materials is unavoidable.
(e)(2)(ii)(H) Before disposal all waste from work areas and from animal rooms shall either be incinerated or decontaminated by a method such
as autoclaving known to effectively destroy bloodborne pathogens.
(e)(2)(ii)(I) Vacuum lines shall be protected with liquid disinfectant traps and high-efficiency particulate air (HEPA) filters or filters of equivalent
or superior efficiency and which are checked routinely and maintained or replaced as necessary.
(e)(2)(ii)(J) Hypodermic needles and syringes shall be used only for parenteral injection and aspiration of fluids from laboratory animals and
diaphragm bottles. Only needle-locking syringes or disposable syringe-needle units (i.e., the needle is integral to the syringe) shall be used for
the injection or aspiration of other potentially infectious materials. Extreme caution shall be used when handling needles and syringes. A
needle shall not be bent, sheared, replaced in the sheath or guard, or removed from the syringe following use. The needle and syringe shall
be promptly placed in a puncture-resistant container and autoclaved or decontaminated before reuse or disposal.
(e)(2)(ii)(K) All spills shall be immediately contained and cleaned up by appropriate professional staff or others properly trained and equipped
to work with potentially concentrated infectious materials.
(e)(2)(ii)(L) A spill or accident that results in an exposure incident shall be immediately reported to the laboratory director or other responsible
person.
(e)(2)(ii)(M) A biosafety manual shall be prepared or adopted and periodically reviewed and updated at least annually or more often if
necessary. Personnel shall be advised of potential hazards, shall be required to read instructions on practices and procedures, and shall be
required to follow them.
(e)(2)(iii) Containment Equipment.
(e)(2)(iii)(A) Certified biological safety cabinets (Class I, II, or III) or other appropriate combinations of personal protection or physical
containment devices, such as special protective clothing, respirators, centrifuge safety cups, sealed centrifuge rotors, and containment caging
for animals, shall be used for all activities with other potentially infectious materials that pose a threat of exposure to droplets, splashes, spills,
or aerosols.
(e)(2)(iii)(B) Biological safety cabinets shall be certified when installed, whenever they are moved and at least annually.
(e)(3) HIV and HBV research laboratories shall meet the following criteria:
(e)(3)(i) Each laboratory shall contain a facility for hand washing and an eye wash facility which is readily available within the work area.
(e)(3)(ii) An autoclave for decontamination of regulated waste shall be available.
(e)(4) HIV and HBV production facilities shall meet the following criteria:
(e)(4)(i) The work areas shall be separated from areas that are open to unrestricted traffic flow within the building. Passage through two sets of
doors shall be the basic requirement for entry into the work area from access corridors or other contiguous areas. Physical separation of the
high-containment work area from access corridors or other areas or activities may also be provided by a double-doored clothes-change room
(showers may be included), airlock, or other access facility that requires passing through two sets of doors before entering the work area.
(e)(4)(ii) The surfaces of doors, walls, floors and ceilings in the work area shall be water resistant so that they can be easily cleaned.
Penetrations in these surfaces shall be sealed or capable of being sealed to facilitate decontamination.
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(e)(4)(iii) Each work area shall contain a sink for washing hands and a readily available eye wash facility. The sink shall be foot, elbow, or
automatically operated and shall be located near the exit door of the work area.
(e)(4)(iv) Access doors to the work area or containment module shall be self-closing.
(e)(4)(v) An autoclave for decontamination of regulated waste shall be available within or as near as possible to the work area.
(e)(4)(vi) A ducted exhaust-air ventilation system shall be provided. This system shall create directional airflow that draws air into the work
area through the entry area. The exhaust air shall not be recirculated to any other area of the building, shall be discharged to the outside, and
shall be dispersed away from occupied areas and air intakes. The proper direction of the airflow shall be verified (i.e., into the work area).
(e)(5) Training Requirements. Additional training requirements for employees in HIV and HBV research laboratories and HIV and HBV
production facilities are specified in paragraph (g)(2)(ix).
(f) Hepatitis B Vaccination and Post-exposure Evaluation and Follow-up (f)(1) General.
(f)(1)(i) The employer shall make available the hepatitis B vaccine and vaccination series to all employees who have occupational exposure,
and post-exposure evaluation and follow-up to all employees who have had an exposure incident.
(f)(1)(ii) The employer shall ensure that all medical evaluations and procedures including the hepatitis B vaccine and vaccination series and
post-exposure evaluation and follow-up, including prophylaxis, are:
(f)(1)(ii)(A) Made available at no cost to the employee;
(f)(1)(ii)(B) Made available to the employee at a reasonable time and place;
(f)(1)(ii)(C) Performed by or under the supervision of a licensed physician or by or under the supervision of another licensed healthcare
professional; and
(f)(1)(ii)(D) Provided according to recommendations of the U.S. Public Health Service current at the time these evaluations and procedures
take place, except as specified by this paragraph (f).
(f)(1)(iii) The employer shall ensure that all laboratory tests are conducted by an accredited laboratory at no cost to the employee.
(f)(2) Hepatitis B Vaccination.
(f)(2)(i) Hepatitis B vaccination shall be made available after the employee has received the training required in paragraph (g)(2)(vii)(I) and
within 10 working days of initial assignment to all employees who have occupational exposure unless the employee has previously received
the complete hepatitis B vaccination series, antibody testing has revealed that the employee is immune, or the vaccine is contraindicated for
medical reasons.
(f)(2)(ii) The employer shall not make participation in a prescreening program a prerequisite for receiving hepatitis B vaccination.
(f)(2)(iii) If the employee initially declines hepatitis B vaccination but at a later date while still covered under the standard decides to accept the
vaccination, the employer shall make available hepatitis B vaccination at that time.
(f)(2)(iv) The employer shall assure that employees who decline to accept hepatitis B vaccination offered by the employer sign the statement
in Appendix A.
(f)(2)(v) If a routine booster dose(s) of hepatitis B vaccine is recommended by the U.S. Public Health Service at a future date, such booster
dose(s) shall be made available in accordance with section (f)(1)(ii).
(f)(3) Post-exposure Evaluation and Follow-up. Following a report of an exposure incident, the employer shall make immediately available
to the exposed employee a confidential medical evaluation and follow-up, including at least the following elements:
(f)(3)(i) Documentation of the route(s) of exposure, and the circumstances under which the exposure incident occurred;
(f)(3)(ii) Identification and documentation of the source individual, unless the employer can establish that identification is infeasible or
prohibited by state or local law;
(f)(3)(ii)(A) The source individual's blood shall be tested as soon as feasible and after consent is obtained in order to determine HBV and HIV
infectivity. If consent is not obtained, the employer shall establish that legally required consent cannot be obtained. When the source
individual's consent is not required by law, the source individual's blood, if available, shall be tested and the results documented.
(f)(3)(ii)(B) When the source individual is already known to be infected with HBV or HIV, testing for the source individual's known HBV or HIV
status need not be repeated.
(f)(3)(ii)(C) Results of the source individual's testing shall be made available to the exposed employee, and the employee shall be informed of
applicable laws and regulations concerning disclosure of the identity and infectious status of the source individual.
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(f)(3)(iii) Collection and testing of blood for HBV and HIV serological status;
(f)(3)(iii)(A) The exposed employee's blood shall be collected as soon as feasible and tested after consent is obtained.
(f)(3)(iii)(B) If the employee consents to baseline blood collection, but does not give consent at that time for HIV serologic testing, the sample
shall be preserved for at least 90 days. If, within 90 days of the exposure incident, the employee elects to have the baseline sample tested,
such testing shall be done as soon as feasible.
(f)(3)(iv) Post-exposure prophylaxis, when medically indicated, as recommended by the U.S. Public Health Service;
(f)(3)(v) Counseling; and
(f)(3)(vi) Evaluation of reported illnesses.
(f)(4) Information Provided to the Healthcare Professional.
(f)(4)(i) The employer shall ensure that the healthcare professional responsible for the employee's Hepatitis B vaccination is provided a copy
of this regulation.
(f)(4)(ii) The employer shall ensure that the healthcare professional evaluating an employee after an exposure incident is provided the
following information:
(f)(4)(ii)(A) A copy of this regulation;
(f)(4)(ii)(B) A description of the exposed employee's duties as they relate to the exposure incident;
(f)(4)(ii)(C) Documentation of the route(s) of exposure and circumstances under which exposure occurred;
(f)(4)(ii)(D) Results of the source individual's blood testing, if available; and
(f)(4)(ii)(E) All medical records relevant to the appropriate treatment of the employee including vaccination status which are the employer's
responsibility to maintain.
(f)(5) Healthcare Professional's Written Opinion. The employer shall obtain and provide the employee with a copy of the evaluating
healthcare professional's written opinion within 15 days of the completion of the evaluation.
(f)(5)(i) The healthcare professional's written opinion for Hepatitis B vaccination shall be limited to whether Hepatitis B vaccination is indicated
for an employee, and if the employee has received such vaccination.
(f)(5)(ii) The healthcare professional's written opinion for post-exposure evaluation and follow-up shall be limited to the following information:
(f)(5)(ii)(A) That the employee has been informed of the results of the evaluation; and
(f)(5)(ii)(B) That the employee has been told about any medical conditions resulting from exposure to blood or other potentially infectious
materials which require further evaluation or treatment.
(f)(5)(iii) All other findings or diagnoses shall remain confidential and shall not be included in the written report.
(f)(6) Medical Recordkeeping. Medical records required by this standard shall be maintained in accordance with paragraph (h)(1) of this
section.
(g) Communication of Hazards to Employees (g)(1) Labels and Signs (g)(1)(i) Labels.
(g)(1)(i)(A) Warning labels shall be affixed to containers of regulated waste, refrigerators and freezers containing blood or other potentially
infectious material; and other containers used to store, transport or ship blood or other potentially infectious materials, except as provided in
paragraph (g)(1)(i)(E), (F) and (G).
(g)(1)(i)(B) Labels required by this section shall include the following legend:
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(g)(1)(i)(C) These labels shall be fluorescent orange or orange-red or predominantly so, with lettering and symbols in a contrasting color.
(g)(1)(i)(D) Labels shall be affixed as close as feasible to the container by string, wire, adhesive, or other method that prevents their loss or
unintentional removal.
(g)(1)(i)(E) Red bags or red containers may be substituted for labels.
(g)(1)(i)(F) Containers of blood, blood components, or blood products that are labeled as to their contents and have been released for
transfusion or other clinical use are exempted from the labeling requirements of paragraph (g).
(g)(1)(i)(G) Individual containers of blood or other potentially infectious materials that are placed in a labeled container during storage,
transport, shipment or disposal are exempted from the labeling requirement.
(g)(1)(i)(H) Labels required for contaminated equipment shall be in accordance with this paragraph and shall also state which portions of the
equipment remain contaminated.
(g)(1)(i)(I) Regulated waste that has been decontaminated need not be labeled or color-coded.
(g)(1)(ii) Signs.
(g)(1)(ii)(A) The employer shall post signs at the entrance to work areas specified in paragraph (e), HIV and HBV Research Laboratory and
Production Facilities, which shall bear the following legend:

(Name of the Infectious Agent)
(Special requirements for entering the area)
(Name, telephone number of the laboratory director or other responsible person.)
(g)(1)(ii)(B) These signs shall be fluorescent orange-red or predominantly so, with lettering and symbols in a contrasting color.
(g)(2) Information and Training.
(g)(2)(i) Employers shall ensure that all employees with occupational exposure participate in a training program which must be provided at no
cost to the employee and during working hours.
(g)(2)(ii) Training shall be provided as follows:
(g)(2)(ii)(A) At the time of initial assignment to tasks where occupational exposure may take place;
(g)(2)(ii)(B) Within 90 days after the effective date of the standard; and
(g)(2)(ii)(C) At least annually thereafter.
(g)(2)(iii) For employees who have received training on bloodborne pathogens in the year preceding the effective date of the standard, only
training with respect to the provisions of the standard which were not included need be provided.
(g)(2)(iv) Annual training for all employees shall be provided within one year of their previous training.
(g)(2)(v) Employers shall provide additional training when changes such as modification of tasks or procedures or institution of new tasks or
procedures affect the employee's occupational exposure. The additional training may be limited to addressing the new exposures created.

44

(g)(2)(vi) Material appropriate in content and vocabulary to educational level, literacy, and language of employees shall be used.
(g)(2)(vii) The training program shall contain at a minimum the following elements:
(g)(2)(vii)(A) An accessible copy of the regulatory text of this standard and an explanation of its contents;
(g)(2)(vii)(B) A general explanation of the epidemiology and symptoms of bloodborne diseases;
(g)(2)(vii)(C) An explanation of the modes of transmission of bloodborne pathogens;
(g)(2)(vii)(D) An explanation of the employer's exposure control plan and the means by which the employee can obtain a copy of the written
plan;
(g)(2)(vii)(E) An explanation of the appropriate methods for recognizing tasks and other activities that may involve exposure to blood and other
potentially infectious materials;
(g)(2)(vii)(F) An explanation of the use and limitations of methods that will prevent or reduce exposure including appropriate engineering
controls, work practices, and personal protective equipment;
(g)(2)(vii)(G) Information on the types, proper use, location, removal, handling, decontamination and disposal of personal protective
equipment;
(g)(2)(vii)(H) An explanation of the basis for selection of personal protective equipment;
(g)(2)(vii)(I) Information on the hepatitis B vaccine, including information on its efficacy, safety, method of administration, the benefits of being
vaccinated, and that the vaccine and vaccination will be offered free of charge;
(g)(2)(vii)(J) Information on the appropriate actions to take and persons to contact in an emergency involving blood or other potentially
infectious materials;
(g)(2)(vii)(K) An explanation of the procedure to follow if an exposure incident occurs, including the method of reporting the incident and the
medical follow-up that will be made available;
(g)(2)(vii)(L) Information on the post-exposure evaluation and follow-up that the employer is required to provide for the employee following an
exposure incident;
(g)(2)(vii)(M) An explanation of the signs and labels and/or color coding required by paragraph (g)(1); and
(g)(2)(vii)(N) An opportunity for interactive questions and answers with the person conducting the training session.
(g)(2)(viii) The person conducting the training shall be knowledgeable in the subject matter covered by the elements contained in the training
program as it relates to the workplace that the training will address.
(g)(2)(ix) Additional Initial Training for Employees in HIV and HBV Laboratories and Production Facilities. Employees in HIV or HBV research
laboratories and HIV or HBV production facilities shall receive the following initial training in addition to the above training requirements.
(g)(2)(ix)(A) The employer shall assure that employees demonstrate proficiency in standard microbiological practices and techniques and in
the practices and operations specific to the facility before being allowed to work with HIV or HBV.
(g)(2)(ix)(B) The employer shall assure that employees have prior experience in the handling of human pathogens or tissue cultures before
working with HIV or HBV.
(g)(2)(ix)(C) The employer shall provide a training program to employees who have no prior experience in handling human pathogens. Initial
work activities shall not include the handling of infectious agents. A progression of work activities shall be assigned as techniques are learned
and proficiency is developed. The employer shall assure that employees participate in work activities involving infectious agents only after
proficiency has been demonstrated.
(h) Recordkeeping (h)(1) Medical Records.
(h)(1)(i) The employer shall establish and maintain an accurate record for each employee with occupational exposure, in accordance with 29
CFR 1910.1020.
(h)(1)(ii) This record shall include:
(h)(1)(ii)(A) The name and social security number of the employee;
(h)(1)(ii)(B) A copy of the employee's hepatitis B vaccination status including the dates of all the hepatitis B vaccinations and any medical
records relative to the employee's ability to receive vaccination as required by paragraph (f)(2);
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(h)(1)(ii)(C) A copy of all results of examinations, medical testing, and follow-up procedures as required by paragraph (f)(3);
(h)(1)(ii)(D) The employer's copy of the healthcare professional's written opinion as required by paragraph (f)(5); and
(h)(1)(ii)(E) A copy of the information provided to the healthcare professional as required by paragraphs (f)(4)(ii)(B)(C) and (D).
(h)(1)(iii) Confidentiality. The employer shall ensure that employee medical records required by paragraph (h)(1) are:
(h)(1)(iii)(A) Kept confidential; and
(h)(1)(iii)(B) Not disclosed or reported without the employee's express written consent to any person within or outside the workplace except as
required by this section or as may be required by law.
(h)(1)(iv) The employer shall maintain the records required by paragraph (h) for at least the duration of employment plus 30 years in
accordance with 29 CFR 1910.1020.
(h)(2) Training Records.
(h)(2)(i) Training records shall include the following information:
(h)(2)(i)(A) The dates of the training sessions;
(h)(2)(i)(B) The contents or a summary of the training sessions;
(h)(2)(i)(C) The names and qualifications of persons conducting the training; and
(h)(2)(i)(D) The names and job titles of all persons attending the training sessions.
(h)(2)(ii) Training records shall be maintained for 3 years from the date on which the training occurred.
(h)(3) Availability.
(h)(3)(i) The employer shall ensure that all records required to be maintained by this section shall be made available upon request to the
Assistant Secretary and the Director for examination and copying.
(h)(3)(ii) Employee training records required by this paragraph shall be provided upon request for examination and copying to employees, to
employee representatives, to the Director, and to the Assistant Secretary.
(h)(3)(iii) Employee medical records required by this paragraph shall be provided upon request for examination and copying to the subject
employee, to anyone having written consent of the subject employee, to the Director, and to the Assistant Secretary in accordance with 29
CFR 1910.1020.
(h)(4) Transfer of Records.
(h)(4)(i) The employer shall comply with the requirements involving transfer of records set forth in 29 CFR 1910.1020(h).
(h)(4)(ii) If the employer ceases to do business and there is no successor employer to receive and retain the records for the prescribed period,
the employer shall notify the Director, at least three months prior to their disposal and transmit them to the Director, if required by the Director
to do so, within that three month period.
(h)(5) Sharps Injury Log.
(h)(5)(i) The employer shall establish and maintain a sharps injury log for the recording of percutaneous injuries from contaminated sharps.
The information in the sharps injury log shall be recorded and maintained in such manner as to protect the confidentiality of the injured
employee. The sharps injury log shall contain, at a minimum:
(h)(5)(i)(A) the type and brand of device involved in the incident,
(h)(5)(i)(B) the department or work area where the exposure incident occurred, and
(h)(5)(i)(C) an explanation of how the incident occurred.
(h)(5)(ii) The requirement to establish and maintain a sharps injury log shall apply to any employer who is required to maintain a log of
occupational injuries and illnesses under 29 CFR 1904.
(h)(5)(iii) The sharps injury log shall be maintained for the period required by 29 CFR 1904.6.
(i) Dates (i)(1) Effective Date. The standard shall become effective on March 6, 1992.
(i)(2) The Exposure Control Plan required by paragraph (c) of this section shall be completed on or before May 5, 1992.
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(i)(3) Paragraph (g)(2) Information and Training and (h) Recordkeeping shall take effect on or before June 4, 1992.
(i)(4) Paragraphs (d)(2) Engineering and Work Practice Controls, (d)(3) Personal Protective Equipment, (d)(4) Housekeeping, (e) HIV and
HBV Research Laboratories and Production Facilities, (f) Hepatitis B Vaccination and Post-Exposure Evaluation and Follow-up, and (g)(1)
Labels and Signs, shall take effect July 6, 1992.
APPENDIX A TO SECTION 1910.1030 - HEPATITIS B DECLINATION (MANDATORY)
I understand that due to my occupational exposure to blood or other potentially infectious materials I may be at risk of acquiring hepatitis B
virus (HBV) infection. I have been given the opportunity to be vaccinated with hepatitis B vaccine, at no charge to myself. However, I decline
hepatitis B vaccination at this time. I understand that by declining this vaccine, I continue to be at risk of acquiring hepatitis B, a serious
disease. If in the future I continue to have occupational exposure to blood or other potentially infectious materials and I want to be vaccinated
with hepatitis B vaccine, I can receive the vaccination series at no charge to me.
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